Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • LZE GmbH Introduces Fraunhofer’s RFicient® Technology to the Market

    March 12, 2026

    LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step [...]

  • Fourth Appoints Veteran Product Leader Scott Collison as CEO

    March 12, 2026

    Fourth, a leading provider of workforce and inventory management solutions for the hospitality industry, today announced the appointment of Scott Collison as Chief Executive Officer. A proven builder of enterprise software platforms with more than two decades of experience scaling technology companies, Collison will lead Fourth into its next phase of AI-led product innovation for [...]

  • Cryptio Raises $45m Series B as Digital Assets Move Into Regulated Financial Markets

    March 12, 2026

    The system of record for tokenized finance – ERP infrastructure for institutions operating in digital assets

  • Waiv Secures $33 Million to Scale AI Precision Testing

    March 12, 2026

    Waiv, a Paris-based startup, spins out of Owkin to accelerate AI-enabled precision oncology testing

  • Alchelyst and Lyra Client Solutions Complete Combination, Creating a Purpose-Built Platform to Support the Evolving Needs of Private Markets

    March 12, 2026

    Newly combined company will focus on delivering technology-enabled client service and next-generation infrastructure to support the growth of private markets firms

  • Argan, Inc. to Announce Fourth Quarter and Fiscal Year-End 2026 Results and Host Conference Call on Thursday, March 26, 2026

    March 12, 2026

    Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2026 financial results after the market closes on Thursday, March 26, 2026. Management will host a webcast with an accompanying slide presentation and conference call on Thursday, March 26, 2026 at 5:00 p.m. ET. [...]

  • UK Fintech Legado Nears 500,000 Users as Financial Services Sector Rushes to Adopt More Digital Infrastructure

    March 12, 2026

    Legado, which supports financial institutions in modernising customer communications and document management via its tech platform, counts FNZ, Quilter, Scottish Building Society, Moneyhub, and Co-op Legal Services among its client base

  • Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program

    March 12, 2026

    — Competitive Grant Program to Offer Individual Grants of Up to $10,000 per Project — — Inaugural Application Cycle Open to Licensed Psychiatric-Mental Health Nurse Practitioners Across Multiple Clinical Settings — — Application Period to Run From March 16, 2026 Through June 1, 2026 —

  • Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF)

    March 12, 2026

    Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by complex and redundant biological pathways, limiting the effectiveness of single-target approaches. Baseimmune uses advanced computational protein design to target multiple pro-fibrotic pathways simultaneously. Initially focused on IPF, where approved single-target therapies only slow lung function decline. Fibrosis pipeline advancing toward proof-of-concept efficacy readouts in 2026 and 2027. Assembled world-class Scientific Advisory Board: John Cijiang He, Scott L. Friedman, Toby Maher, Paul Noble, and Joel Rurik.

  • Coats Releases 2025 Sustainability Report, Achieving Key 2026 Targets One Year Ahead of Schedule

    March 12, 2026

    Company meets energy, waste and people targets early, reinforces commitment to sustainability leadership across apparel and footwear industry Achieved zero waste to landfill one year ahead of schedule and delivered a 30% reduction in Scope 1 & 2 emissions, surpassing 2026 target by nearly 40% Accelerated materials transition, with non-virgin oil-based options representing 52% of its primary raw materials, supported by launch of first Textile-to-Textile 100% recycled polyester thread under its T2T Epic™ and T2T Gramax™ brands Increased representation of women in senior leadership positions to 33% and secured Great Place to Work® coverage for 99% of its population, surpassing 2026 targets for both

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • …
  • Page 229
  • Next

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook